Vincent Soriano

42.2k total citations · 1 hit paper
991 papers, 26.3k citations indexed

About

Vincent Soriano is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Vincent Soriano has authored 991 papers receiving a total of 26.3k indexed citations (citations by other indexed papers that have themselves been cited), including 520 papers in Infectious Diseases, 415 papers in Epidemiology and 395 papers in Hepatology. Recurrent topics in Vincent Soriano's work include HIV/AIDS drug development and treatment (444 papers), Hepatitis C virus research (386 papers) and HIV Research and Treatment (364 papers). Vincent Soriano is often cited by papers focused on HIV/AIDS drug development and treatment (444 papers), Hepatitis C virus research (386 papers) and HIV Research and Treatment (364 papers). Vincent Soriano collaborates with scholars based in Spain, United States and United Kingdom. Vincent Soriano's co-authors include Pablo Barreiro, Carmen de Mendoza, Juan González‐Lahoz, Luz Martı́n-Carbonero, Pablo Labarga, Marina Núñez, Eugenia Vispo, Javier García‐Samaniego, Eva Poveda and Sonia Rodríguez‐Nóvoa and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Vincent Soriano

958 papers receiving 25.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sociodemographic and psychological variables influencing adherence to antiretroviral therapy

1999 559 citations Vincent Soriano et al. AIDS profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vincent Soriano Spain	73	14.1k	12.3k	11.0k	9.3k	2.9k	991	26.3k
Christine Katlama France	82	17.3k 1.2×	11.0k 0.9×	5.7k 0.5×	15.0k 1.6×	4.5k 1.6×	595	29.6k
Michael P. Busch United States	80	10.2k 0.7×	11.2k 0.9×	6.9k 0.6×	6.7k 0.7×	1.3k 0.4×	647	29.2k
Richard A. Kaslow United States	61	6.6k 0.5×	6.8k 0.6×	3.6k 0.3×	7.5k 0.8×	1.1k 0.4×	221	19.8k
Michael S. Saag United States	84	19.4k 1.4×	9.5k 0.8×	1.8k 0.2×	15.5k 1.7×	4.7k 1.6×	328	28.8k
Adriano Lazzarin Italy	70	12.2k 0.9×	6.2k 0.5×	2.3k 0.2×	10.9k 1.2×	3.4k 1.2×	616	20.6k
John Phair United States	69	11.0k 0.8×	7.6k 0.6×	1.6k 0.1×	9.5k 1.0×	3.0k 1.1×	353	22.0k
Sharon R. Lewin Australia	67	8.0k 0.6×	6.6k 0.5×	2.8k 0.3×	9.9k 1.1×	2.6k 0.9×	370	19.0k
Bonaventura Clotet Spain	76	16.4k 1.2×	5.1k 0.4×	2.0k 0.2×	15.3k 1.7×	3.6k 1.3×	716	24.8k
Martin Hirsch United States	72	13.6k 1.0×	7.2k 0.6×	1.1k 0.1×	13.0k 1.4×	2.4k 0.8×	274	24.1k
Paul A. Volberding United States	52	13.9k 1.0×	5.8k 0.5×	1.7k 0.2×	10.0k 1.1×	3.0k 1.0×	191	19.8k

Countries citing papers authored by Vincent Soriano

Since Specialization

Citations

This map shows the geographic impact of Vincent Soriano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Soriano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Soriano more than expected).

Fields of papers citing papers by Vincent Soriano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Soriano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Soriano. The network helps show where Vincent Soriano may publish in the future.

Co-authorship network of co-authors of Vincent Soriano

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Soriano. A scholar is included among the top collaborators of Vincent Soriano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Soriano. Vincent Soriano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ramos, José Manuel, Carmen de Mendoza, Víctor Moreno‐Torres, et al.. (2023). Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain. Journal of Clinical Virology. 167. 105553–105553. 6 indexed citations

Soriano, Vincent, et al.. (2023). Triple Threat: HDV, HBV, HIV Coinfection. Clinics in Liver Disease. 27(4). 955–972. 7 indexed citations

Mendoza, Carmen de, Leire Pérez, Ariadna Rando‐Segura, et al.. (2023). HTLV-1-associated myelopathy in Spain. Journal of Clinical Virology. 169. 105619–105619. 8 indexed citations

Atkinson, Victoria, Shahneen Sandhu, Geke A.P. Hospers, et al.. (2020). Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II). Melanoma Research. 30(3). 261–267. 25 indexed citations

Jiménez‐Sousa, María Ángeles, Juan Berenguer, Norma Rallón, et al.. (2016). IL15 polymorphism is associated with advanced fibrosis, inflammation‐related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection. Liver International. 36(9). 1258–1266. 7 indexed citations

Zeuzem, Stefan, Parvez Mantry, Vincent Soriano, et al.. (2016). Short article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study. European Journal of Gastroenterology & Hepatology. 28(8). 923–926. 1 indexed citations

Asselah, Tarik, Stefan Zeuzem, Vincent Soriano, et al.. (2015). ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection. PLoS ONE. 10(12). e0144004–e0144004. 4 indexed citations

Zeuzem, Stefan, Vincent Soriano, Tarik Asselah, et al.. (2014). Efficacy and Safety of Faldaprevir, Deleobuvir, and Ribavirin in Treatment-Naive Patients with Chronic Hepatitis C Virus Infection and Advanced Liver Fibrosis or Cirrhosis. Antimicrobial Agents and Chemotherapy. 59(2). 1282–1291. 8 indexed citations

Rallón, Norma, Juan A. Pineda, Vincent Soriano, et al.. (2012). Differences in Virological Response to Peginterferon-α Plus Ribavirin in HIV-Positive Patients Coinfected With HCV Subtypes 1a or 1b. JAIDS Journal of Acquired Immune Deficiency Syndromes. 60(2). 117–123. 11 indexed citations

10.

Pushpakom, Sudeep, Neill J. Liptrott, Sonia Rodríguez‐Nóvoa, et al.. (2011). Genetic Variants of ABCC10, a Novel Tenofovir Transporter, Are Associated With Kidney Tubular Dysfunction. The Journal of Infectious Diseases. 204(1). 145–153. 82 indexed citations

11.

López, Mariola, Vincent Soriano, Sara Lozano, et al.. (2011). The expansion ability but not the quality of HIV-specific CD8+ T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors. Immunology. 134(3). 305–313. 4 indexed citations

12.

Rallón, Norma, Judit Morelló, Pablo Labarga, et al.. (2011). Impact of Inosine Triphosphatase Gene Variants on the Risk of Anemia in HIV/Hepatitis C Virus-Coinfected Patients Treated for Chronic Hepatitis C. Clinical Infectious Diseases. 53(12). 1291–1295. 10 indexed citations

13.

Rodríguez‐Nóvoa, Sonia, Pablo Labarga, Vincent Soriano, et al.. (2009). Predictors of Kidney Tubular Dysfunction in HIV‐Infected Patients Treated with Tenofovir: A Pharmacogenetic Study. Clinical Infectious Diseases. 48(11). e108–e116. 194 indexed citations

14.

Mendoza, Carmen de, et al.. (2008). Resistencia viral y barrera genética de atazanavir. Enfermedades Infecciosas y Microbiología Clínica. 26. 28–33.

15.

Barreiro, Pablo, et al.. (2005). Nucleoside/nucleotide backbones for the treatment of HIV infection.. PubMed. 6(8). 812–22. 3 indexed citations

16.

Mendoza, Carmen de, Luz Martı́n-Carbonero, Óscar Gallego, et al.. (2005). Relationship between drug resistance mutations, plasma viremia, and CD4⁺T-cell counts in patients with chronic HIV infection. Journal of Medical Virology. 76(1). 1–6. 7 indexed citations

17.

Toro, Carlos, Berta Rodés, Antonio Aguilera, et al.. (2004). Infecciones por VIH-2 y HTLV-I/II en España. Enfermedades Infecciosas y Microbiología Clínica. 22(3). 177–182. 7 indexed citations

18.

Soriano, Vincent, Mark Sulkowski, Colm Bergin, et al.. (2002). Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel. AIDS. 16(6). 813–828. 344 indexed citations

19.

Barrios, Ana, Francisco J. Blanco, Teresa García-Benayas, et al.. (2002). Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia. AIDS. 16(15). 2079–2081. 39 indexed citations

20.

Soriano, Vincent, Juan González‐Lahoz, & Marta Leon‐Monzon. (1993). [Retroviruses and autoimmune diseases].. PubMed. 100(5). 181–6.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact